PPCB short interest
Propanc Biopharma Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 71,162 |
|---|---|
| Change vs prior report | 42,159 (+145.4%) |
| Change over six months | -50.4% |
| Days to cover | 1.00 (sector: 3.78) |
| Average daily volume | 333,944 |
| Rank in Healthcare | #779 of 922 by days to cover |
PPCB short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 71,162 | +145.4% | 1.00 | 333,944 |
| 2026-09-15 | 29,003 | -91.4% | 1.00 | 298,214 |
| 2026-08-31 | 335,967 | +497.2% | 1.00 | 9,115,538 |
| 2026-08-14 | 56,255 | +179.2% | 1.00 | 235,824 |
| 2026-07-31 | 20,152 | -84.9% | 1.00 | 99,223 |
| 2026-07-15 | 133,524 | +689.9% | 1.00 | 5,925,509 |
| 2026-06-30 | 16,903 | -95.2% | 1.00 | 206,327 |
| 2026-06-15 | 352,559 | +1030.0% | 1.00 | 15,852,470 |
| 2026-05-29 | 31,201 | -94.9% | 1.00 | 90,333 |
| 2026-05-15 | 617,010 | +17.8% | 1.00 | 1,040,060 |
| 2026-04-30 | 523,788 | +159.7% | 1.00 | 2,428,344 |
| 2026-04-15 | 201,708 | +40.5% | 1.00 | 11,444,087 |
| 2026-03-31 | 143,588 | -75.5% | 1.00 | 1,403,685 |
| 2026-03-13 | 584,973 | +135.3% | 1.00 | 3,132,682 |
| 2026-02-27 | 248,625 | -26.5% | 1.00 | 423,531 |
| 2026-02-13 | 338,451 | -15.1% | 1.00 | 5,333,686 |
| 2026-01-30 | 398,642 | +104.5% | 1.00 | 1,160,073 |
| 2026-01-15 | 194,883 | -15.7% | 1.65 | 118,032 |
| 2025-12-31 | 231,114 | -2.4% | 3.01 | 76,798 |
| 2025-12-15 | 236,669 | +40.8% | 1.00 | 435,786 |
| 2025-11-28 | 168,107 | -34.7% | 4.11 | 40,860 |
| 2025-11-14 | 257,345 | +32.6% | 1.00 | 373,350 |
| 2025-10-31 | 194,045 | +5.0% | 1.76 | 110,478 |
| 2025-10-15 | 184,848 | -12.9% | 1.00 | 517,109 |
| 2025-09-30 | 212,160 | +12.6% | 1.00 | 211,114 |
import finzdata as yf
yf.Ticker("PPCB").short_interest # every report since 2017
yf.Client().short_interest(["PPCB"], start="2018-01-01")Healthcare short interest · PPCB price history · Who owns PPCB · All short interest